![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 29, 20083-20091, July 16, 1999
§,
,
,
,
§,
§
From the Departments of Analysis of purified soybean and rabbit
reticulocyte 15-lipoxygenase (15-LOX) and PA317 cells transfected with
human 15-LOX revealed a rapid rate of linoleate-dependent
nitric oxide (·NO) uptake that coincided with reversible
inhibition of product ((13S)-hydroperoxyoctadecadienoic
acid, or (13S)-HPODE) formation. No reaction of ·NO
(up to 2 µM) with either native (Ered) or
ferric LOXs (0.2 µM) metal centers to form nitrosyl
complexes occurred at these ·NO concentrations. During
HPODE-dependent activation of 15-LOX, there was consumption
of 2 mol of ·NO/mol of 15-LOX. Stopped flow fluorescence
spectroscopy showed that ·NO (2.2 µM) did not
alter the rate or extent of (13S)-HPODE-induced tryptophan
fluorescence quenching associated with 15-LOX activation. Additionally,
·NO does not inhibit the anaerobic peroxidase activity of
15-LOX, inferring that the inhibitory actions of ·NO are due to
reaction with the enzyme-bound lipid peroxyl radical, rather than
impairment of (13S)-HPODE-dependent enzyme
activation. From this, a mechanism of 15-LOX inhibition by ·NO
is proposed whereby reaction of ·NO with
EredLOO· generates Ered and LOONO, which
hydrolyzes to (13S)-HPODE and nitrite
(NO2
Anesthesiology,
¶ Biochemistry and Molecular Genetics, and
§§ Pathology and the § Center for
Free Radical Biology, University of Alabama at Birmingham, Birmingham,
Alabama 35233, the
Department of Obstetrics and Gynecology,
Emory University, Atlanta, Georgia 30322, the ** Institute of
Biochemistry, Humboldt University, Hessische Strasse 3-4 Berlin,
Germany, and the 
Institute of Pharmacology,
Freie University, Thielalle 69-73 Berlin, Germany
). Reactivation of
Ered, considerably slower than dioxygenase activity, is
then required to complete the catalytic cycle and leads to a net
inhibition of rates of (13S)-HPODE formation. This reaction
of ·NO with 15-LOX inhibited ·NO-dependent
activation of soluble guanylate cyclase and consequent cGMP production.
Since accelerated ·NO production, enhanced 15-LOX gene
expression, and 15-LOX product formation occurs in diverse inflammatory
conditions, these observations indicate that reactions of ·NO
with lipoxygenase peroxyl radical intermediates will result in
modulation of both ·NO bioavailability and rates of production
of lipid signaling mediators.
This article has been cited by other articles:
![]() |
H. Viita, J. Markkanen, E. Eriksson, M. Nurminen, K. Kinnunen, M. Babu, T. Heikura, S. Turpeinen, S. Laidinen, T. Takalo, et al. 15-Lipoxygenase-1 Prevents Vascular Endothelial Growth Factor A- and Placental Growth Factor-Induced Angiogenic Effects in Rabbit Skeletal Muscles via Reduction in Growth Factor mRNA Levels, NO Bioactivity, and Downregulation of VEGF Receptor 2 Expression Circ. Res., February 1, 2008; 102(2): 177 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Hall and J. Garthwaite Inactivation of nitric oxide by rat cerebellar slices J. Physiol., December 1, 2006; 577(2): 549 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Williams, M. J. Coffey, B. Coles, S. Sanchez, J. D. Morrow, J. R. Cockcroft, M. J. Lewis, and V. B. O'Donnell In vivo aspirin supplementation inhibits nitric oxide consumption by human platelets Blood, October 15, 2005; 106(8): 2737 - 2743. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gupta, C. R. White, S. Handattu, D. W. Garber, G. Datta, M. Chaddha, L. Dai, S. H. Gianturco, W. A. Bradley, and G.M. Anantharamaiah Apolipoprotein E Mimetic Peptide Dramatically Lowers Plasma Cholesterol and Restores Endothelial Function in Watanabe Heritable Hyperlipidemic Rabbits Circulation, June 14, 2005; 111(23): 3112 - 3118. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Schopfer, P. R. S. Baker, G. Giles, P. Chumley, C. Batthyany, J. Crawford, R. P. Patel, N. Hogg, B. P. Branchaud, J. R. Lancaster Jr., et al. Fatty Acid Transduction of Nitric Oxide Signaling: NITROLINOLEIC ACID IS A HYDROPHOBICALLY STABILIZED NITRIC OXIDE DONOR J. Biol. Chem., May 13, 2005; 280(19): 19289 - 19297. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Anning, B. Coles, A. Bermudez-Fajardo, P. E.M. Martin, B. S. Levison, S. L. Hazen, C. D. Funk, H. Kuhn, and V. B. O'Donnell Elevated Endothelial Nitric Oxide Bioactivity and Resistance to Angiotensin-Dependent Hypertension in 12/15-Lipoxygenase Knockout Mice Am. J. Pathol., March 1, 2005; 166(3): 653 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Lim, S. Sweeney, A. Bloodsworth, C. R. White, P. H. Chumley, N. R. Krishna, F. Schopfer, V. B. O'Donnell, J. P. Eiserich, and B. A. Freeman Nitrolinoleate, a nitric oxide-derived mediator of cell function: Synthesis, characterization, and vasomotor activity PNAS, December 10, 2002; 99(25): 15941 - 15946. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Clark, M. J. Coffey, R. M. Maclean, P. W. Collins, M. J. Lewis, A. R. Cross, and V. B. O'Donnell Characterization of Nitric Oxide Consumption Pathways by Normal, Chronic Granulomatous Disease and Myeloperoxidase-Deficient Human Neutrophils J. Immunol., November 15, 2002; 169(10): 5889 - 5896. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Coffey, R. Natarajan, P. H. Chumley, B. Coles, P.-R. Thimmalapura, M. Nowell, H. Kuhn, M. J. Lewis, B. A. Freeman, and V. B. O'Donnell Catalytic consumption of nitric oxide by 12/15- lipoxygenase: Inhibition of monocyte soluble guanylate cyclase activation PNAS, June 20, 2001; (2001) 141136098. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shiva, P. S. Brookes, R. P. Patel, P. G. Anderson, and V. M. Darley-Usmar Nitric oxide partitioning into mitochondrial membranes and the control of respiration at cytochrome c oxidase PNAS, June 19, 2001; 98(13): 7212 - 7217. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. ODonnell and B. A. Freeman Interactions Between Nitric Oxide and Lipid Oxidation Pathways : Implications for Vascular Disease Circ. Res., January 19, 2001; 88(1): 12 - 21. [Abstract] [Full Text] |
||||
![]() |
D. Tomasian, J. F. Keaney Jr., and J. A. Vita Antioxidants and the bioactivity of endothelium-derived nitric oxide Cardiovasc Res, August 18, 2000; 47(3): 426 - 435. [Full Text] [PDF] |
||||
![]() |
R. P. Patel, A.-L. Levonen, J. H. Crawford, and V. M. Darley-Usmar Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis Cardiovasc Res, August 18, 2000; 47(3): 465 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bloodsworth, V. B. O'Donnell, and B. A. Freeman Nitric Oxide Regulation of Free Radical- and Enzyme-Mediated Lipid and Lipoprotein Oxidation Arterioscler. Thromb. Vasc. Biol., July 1, 2000; 20(7): 1707 - 1715. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Rubbo, R. Radi, D. Anselmi, M. Kirk, S. Barnes, J. Butler, J. P. Eiserich, and B. A. Freeman Nitric Oxide Reaction with Lipid Peroxyl Radicals Spares alpha -Tocopherol during Lipid Peroxidation. GREATER OXIDANT PROTECTION FROM THE PAIR NITRIC OXIDE/alpha -TOCOPHEROL THAN alpha -TOCOPHEROL/ASCORBATE J. Biol. Chem., April 6, 2000; 275(15): 10812 - 10818. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. O'Donnell, B. Coles, M. J. Lewis, B. C. Crews, L. J. Marnett, and B. A. Freeman Catalytic Consumption of Nitric Oxide by Prostaglandin H Synthase-1 Regulates Platelet Function J. Biol. Chem., December 1, 2000; 275(49): 38239 - 38244. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Abu-Soud and S. L. Hazen Nitric Oxide Is a Physiological Substrate for Mammalian Peroxidases J. Biol. Chem., November 22, 2000; 275(48): 37524 - 37532. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Coffey, R. Natarajan, P. H. Chumley, B. Coles, P.-R. Thimmalapura, M. Nowell, H. Kuhn, M. J. Lewis, B. A. Freeman, and V. B. O'Donnell Catalytic consumption of nitric oxide by 12/15- lipoxygenase: Inhibition of monocyte soluble guanylate cyclase activation PNAS, July 3, 2001; 98(14): 8006 - 8011. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |